ABCLVSGPCR• 6 Months (Normalized)
ABCL vs GPCR (AbCellera Biologics Inc. vs Structure Therapeutics Inc.)
Showing Closing Date Range from Mar, 18 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $11.17
+217.33%
AbCellera Biologics Inc.
Normalized Baseline0.00%
GPCR Performance $38.44
-25.92%
Structure Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABCL LEADS
+243.25%
ABCL outperforming by 243.25%
ABCLGPCR
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL GPCR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ABCL Price | ABCL Gain (%) | GPCR Price | GPCR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $11.17 | +217.33% | $38.44 | -25.92% | +243.25% |
| Sep 11, 2026 | $10.89 | +209.38% | $38.66 | -25.50% | +234.88% |
| Sep 10, 2026 | $10.46 | +197.16% | $39.55 | -23.78% | +220.94% |
| Sep 09, 2026 | $11.05 | +213.92% | $41.23 | -20.54% | +234.46% |
| Sep 08, 2026 | $11.44 | +225.00% | $40.38 | -22.18% | +247.18% |
| Sep 04, 2026 | $11.43 | +224.72% | $47.34 | -8.77% | +233.49% |
| Sep 03, 2026 | $11.57 | +228.69% | $47.34 | -8.77% | +237.46% |
| Sep 02, 2026 | $11.36 | +222.73% | $47.80 | -7.88% | +230.61% |
| Sep 01, 2026 | $11.28 | +220.45% | $47.13 | -9.17% | +229.62% |
| Aug 31, 2026 | $11.48 | +226.14% | $45.91 | -11.52% | +237.66% |
| Aug 28, 2026 | $11.35 | +222.44% | $47.37 | -8.71% | +231.15% |
| Aug 27, 2026 | $12.40 | +252.27% | $49.22 | -5.15% | +257.42% |
| Aug 26, 2026 | $12.24 | +247.73% | $49.35 | -4.89% | +252.62% |
| Aug 25, 2026 | $12.50 | +255.11% | $49.92 | -3.80% | +258.91% |
| Aug 24, 2026 | $10.61 | +201.42% | $49.01 | -5.55% | +206.97% |
Page 1 of 9